Animal-to-human organ transplants, or "xenotransplantation," raises some challenging questions: whether it's acceptable to make changes in God's creation, what risks these transplants might pose to recipients, and whether they merit the financial cost involved. These issues and others were explored by the United Church in a June 2001 biotechnology consultation and work with medical doctors and ethicists, and a policy proposal and background paper were approved by the April 2002 meeting of the General Council Executive.
Since that time, the church has continued to work on biotechnology issues, including a policy on genetically modified food and the patenting of life.
For more information, contact:
(Note: The United Church of Canada is not responsible for the content of external sites - links will open in new window)